Pays: Suisse
Langue: français
Source: Swissmedic (Swiss Agency for Therapeutic Products)
O-(2-hydroxyéthyl)-rutosidea
Spirig HealthCare AG
C05CA54
O-(2-hydroxyethyl)-rutosidea
Poudre
O-(2-hydroxyethyl)-rutosidea 1000.00 mg, mannitolum, saccharinum natricum corresp. natrium 1.12 mg, acidum citricum monohydricum, ad pulverem, pro charta.
D
Synthetika
En Cas De Troubles Veineux
zugelassen
1996-09-27